Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ARNA 6.16 -0.18 (-2.84%)
price chart
Arena Pharmaceuticals' Belviq Sales Dip - Why?
Belviq, the anti-obesity drug from Arena Pharmaceuticals (ARNA), saw sales fall over 10% last week according to industry tracking services IMS Health and Symphony Health.
Special News Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Incyte ...  Market News Call
Related articles »  
Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ� (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management.
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The Future Is Encouraging
That being the case, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) seems to have come to the realization that unless it takes proactive steps to expand the market share of its anti-obesity drug Belviq, it might as well miss out on a great opportunity.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): TV Ads For Belviq Launched
Dallas, Texas 04/17/2014 (ustradevoice) - One of the main reasons, analysts and pundits say, why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has not had success with its FDA-approved weight management drug known as Belviq, is lack of awareness.
Small Cap Recent Insider Selling: Arena Pharmaceuticals (NASDAQ:ARNA ...  Tech News
Stocks to Keep Your Eyes On: Twitter Inc. (NYSE:TWTR), Arena Pharmaceuticals ...  Gaining Green
Related articles »  
Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Idera ...
Lakeway, NY - (MARKET NEWS CALL) - 4/23/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Worth Watching Stocks: Inovio Pharmaceuticals, (INO), Arena Pharmaceuticals ...  Techsonian (press release)
Related articles »  
Big Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals ...
Lakeway, NY - (MARKET NEWS CALL) - 4/22/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL ...
Free technical research on ARNA, CELG, PDLI and HEB can be downloaded upon signing up at: http://www.investor-edge.com/905-register On Monday, shares in Arena Pharmaceuticals Inc. gained 2.57% to close the day at $6.38. The stock recorded a ...
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Expecting Sales to hit $150M this ...
Dallas, Texas 03/31/2014 (ustradevoice) - Biopharmaceutical Company, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), expects majority of its revenue for the year to come from its flagship drug, Belviq.
Hot Biotech Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), Ariad ...
One of the main reasons, analysts and pundits say, why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has not had success with its FDA-approved weight management drug known as Belviq, is lack of awareness.
Investor's Watch List -Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Incyte ...  Techsonian (press release)
Related articles »  
Arena - Belviq Sales Up Modestly Heading Into Television Ads
It is certainly an interesting time to be an investor in Arena Pharmaceuticals (ARNA). The company is about 10 months into its launch of the anti-obesity drug Belviq and the equity has taken several lumps along the way.
Related articles »